Feuer, William J.
University of Miami
8 papers on CoChatORCID 0000-0002-9442-3076
Most cited papers
- Verified
Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration
Yehoshua, Z., Alexandre de Amorim Garcia Filho, C., Nunes, R. P., Gregori, G., Penha, F. M., Moshfeghi, A. A., Zhang, K., Sadda, S., Feuer, W., & Rosenfeld, P. J. (2014) · Ophthalmology
Retinal Diseases and TreatmentsComplement system in diseases
Cited by 299
- Verified
Gene Therapy for Leber Hereditary Optic Neuropathy
Feuer, W. J., Schiffman, J. C., Davis, J. L., Porciatti, V., Gonzalez, P., Koilkonda, R. D., Yuan, H., Lalwani, A., Lam, B. L., & Guy, J. (2016) · Ophthalmology
Virus-based gene therapy researchRetinal Development and Disorders
Cited by 230
- Verified
Gene Therapy for Leber Hereditary Optic Neuropathy
Guy, J., Feuer, W. J., Davis, J. L., Porciatti, V., Gonzalez, P. J., Koilkonda, R. D., Yuan, H., Hauswirth, W. W., & Lam, B. L. (2017) · Ophthalmology
Virus-based gene therapy researchRetinal Development and Disorders
Cited by 204
- Verified
Choroideremia gene therapy phase 2 clinical trial: 24-month results
Lam, B. L., Davis, J. L., Gregori, N. Z., MacLaren, R. E., Girach, A., Verriotto, J. D., Rodriguez, B., Rosa, P. R., Zhang, X., & Feuer, W. J. (2019) · American Journal of Ophthalmology
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 161
- Verified
Clinicopathologic correlation of ocular surface squamous neoplasms at Bascom Palmer Eye Institute: 2001 to 2010
Kao, A. A., Galor, A., Karp, C. L., Abdelaziz, A., Feuer, W. J., & Dubovy, S. R. (2012) · Ophthalmology
Ocular Oncology and TreatmentsOcular Surface and Contact Lens
Cited by 102
- Verified · note
Trial End Points and Natural History in Patients With G11778A Leber Hereditary Optic Neuropathy: Preparation for Gene Therapy Clinical Trial
Lam, B. L., Feuer, W. J., Schiffman, J. C., Porciatti, V., Vandenbroucke, R., Rosa, P. R., Gregori, G., & Guy, J. (2014) · JAMA Ophthalmology
Glaucoma and retinal disordersRetinal Development and Disorders
Cited by 96
- Verified
LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profile
Koilkonda, R., Yu, H., Talla, V., Porciatti, V., Feuer, W. J., Hauswirth, W. W., Chiodo, V., Erger, K. E., Boye, S. L., Lewin, A. S., et al. (2014) · Investigative Ophthalmology & Visual Science
Retinal Development and DisordersVirus-based gene therapy research
Cited by 65
- Verified
Leber hereditary optic neuropathy gene therapy: adverse events and visual acuity results of all patient groups
Lam, B. L., Feuer, W. J., Davis, J. L., Porciatti, V., Yu, H., Levy, R. B., Vanner, E., & Guy, J. (2022) · American Journal of Ophthalmology
Virus-based gene therapy researchRetinal Development and Disorders
Cited by 43
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free